Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
Barbara Ann Karmanos Cancer Institute
Barbara Ann Karmanos Cancer Institute
University of Nebraska
University of Nebraska
Fox Chase Cancer Center
Mayo Clinic
OHSU Knight Cancer Institute
Case Comprehensive Cancer Center
Georgetown University
Georgetown University
University of Washington
Alliance for Clinical Trials in Oncology
University of Miami
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Roswell Park Cancer Institute
Sarcoma Alliance for Research through Collaboration